News FDA clears first migraine DTx from Click Therapeutics Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.
Patients New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an... At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.
News Digital health firm XRHealth hits the M&A trial again XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare.
News Kyorin partners Hyfe to develop DTx for chronic cough Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.
News Shionogi gets approval in Japan for ADHD digital therapeutic Shionogi will market the EndeavorRide app, originally licensed from Akili, in Japan following its approval by the MHLW regulator.
News Newel's VR therapy for chronic pain nears EU market Newel Health has been granted EU certification for its VR-based digital therapeutic for chronic pain, clearing the way for its launch in Europe.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.